Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Applications Laboratories Inc

Neither a doctor nor a teaching hospital

Research payments

$540,993

184 payments

Through program year 2025, Clinical Applications Laboratories Inc is reported as receiving $540,993 in research payments, across 184 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $49,985 21
2024 Research $82,019 20
2023 Research $61,143 12
2022 Research $44,675 14
2021 Research $112,418 30
2020 Research $125,017 36
2019 Research $65,736 51

Breakdown

Who paid Research payments · program years 2019–2025
  1. Genentech, Inc. $260,341 79 payments
  2. Roche Products Limited $151,290 59 payments
  3. Chugai Pharmaceutical Co., Ltd. $59,737 2 payments
  4. Ironwood Pharmaceuticals, Inc $32,876 5 payments
  5. Pfizer Inc. $32,493 26 payments
  6. Allergan Inc. $2,965 2 payments
  7. Bausch Health US, LLC $1,218 10 payments
  8. AbbVie, Inc. $73 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. An Open Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II III Studies $116,546 34 payments
  2. Crohn S Disease Program Cohort 1 Induction Cohort II Maintenance $93,890 28 payments
  3. Ole $87,050 30 payments
  4. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biomarkers of Donq52 in Celiac Disease Patients $59,737 2 payments
  5. Crohn S Disease Program Ole $57,401 31 payments
  6. Open Label Maintenance Trial Global $41,822 12 payments
  7. C3718-302 $32,876 5 payments
  8. A Phase 3B4multicenter Doubleblind Randomized Parallel Group Study of Tofacitinib Cp690550 in Subjects With Ulcerative Colitis in Stable Remission $23,858 20 payments
  9. Indxn Main Etro Pbo $14,923 3 payments
  10. A Multicenter Openlabel Study of Cp690550 in Subjects With Moderate to Severe Ulcerative Colitis $6,452 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record